Search Results 601-610 of 18520 for Relapse
Understanding who is more likely to have a relapse of lymphoma and why. Finding ways to improve quality of life after lymphoma treatment. Publications. See a ...
... relapse study design. Participation eligibility. Participant eligibility ... Clinical evidence of at least 2 relapses in last 12 months or 3 relapses in ...
A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin ...
Mayo Clinic researchers link CAR-T cell aging to cancer relapse featured image. Featured News. Mayo Clinic researchers link CAR-T cell aging to cancer relapse.
If you have these changes, call your healthcare professional right away. Relapse to tobacco and nicotine dependence within six months of quitting is a common ...
Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Relapsed/Refractory Large B-cell ...
Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18, 2013. Cancer. Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics ...
Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or ...
A Trial to Evaluate the Efficacy and Safety of MOR208 With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory ...
Is the definition of Alzheimer's disease changing? Dana Sparks. November 6, 2018. Mayo researchers correlate specific antibody with relapse of neurological ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.